Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockbuphoonon Aug 08, 2021 11:12am
113 Views
Post# 33669409

$2.86 - almost another all time low

$2.86 - almost another all time lowNo catalysts except apparently help wanted ads for production jobs at a plant Liminal and a potential voucher sale for $70M. It takes time to consummate a voucher sale and it will take longer than management expect as they think end of 2021 as their target date. They will probably give away some cash similar to Plasma division sale if they get it done quicker. They have cash until end of September with proceeds of plasma sell off so they need to do a financing now or get a bridge loan but it doesn't seem like that is happening after over 2 months of getting the voucher. They are already well in the $22M that they got for plasma collection centres and plasma division. They will either heavily dilute here at much less than $2.86 a share or take it private. Any bets? 

<< Previous
Bullboard Posts
Next >>